News
‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...
Good morning, ladies and gentlemen, and welcome to the Sandoz call today. I will now pass on to Craig Marks, Head of Investor Relations, for his opening remarks. Thank you. Welcome to the Sandoz Q1 ...
We have seen a steady increase in the use of blood based biomarkers, the conversion rates from diagnosis ... ejection fraction indication for Tirzepatide. We believe the positive Phase 3 data ...
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Semaglutide and tirzepatide prescriptions within Epic-affiliated health care systems increased slightly between 2021 and 2024, but their uptake remained limited, with only 3% of eligible patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results